Flexens COVID-19 Saliva Antigen Test Kit Completes European CE Certification

[Asia Economy Reporter Chunhee Lee] Plexense announced on the 30th that its COVID-19 saliva antigen test kit has completed European CE certification.

Plexense's saliva antigen test kit allows the test subject to collect saliva in a storage container and submit it, with results available within 2 hours. Using Plexense's proprietary rapid ELISA diagnostic method, which can quickly analyze large volumes of specimens, rapid testing of large groups is possible. For example, students attending school can self-collect saliva samples in the classroom and send them to the laboratory for analysis, receiving results on the same day. The cost per test is approximately 5,000 KRW, offering price competitiveness at about one-tenth the cost of polymerase chain reaction (PCR) tests, making it suitable for regular screening of large groups.

The distribution rights for Plexense's saliva antigen test kit in Europe and domestically are held by Medicox. Prior to this saliva antigen test kit, Plexense had already obtained European CE certification for its serum antibody test kit and plans to strengthen marketing efforts for it, maximizing synergy with partner companies such as Medicox.

Kim Kibum, CEO of Plexense, stated, "With the product verification process nearing completion for both the saliva antigen test kit and the serum antibody test kit, we plan to actively utilize Medicox's bio-medical business capabilities and cold chain system to focus on exports to European countries such as Germany."

This content was produced with the assistance of AI translation services.